Chief Executive Officer; Oxford/London
Founded in 2017, Oxford Cannabinoid Technologies (OCT) is a biopharmaceutical company focused on researching, developing, and licensing cannabinoid-based compounds and therapies. OCT brings researchers, clinicians and cannabinoid experts to advance their understanding of the medical properties of cannabis and develop new therapies.
OCT was established by UK investment firm Kingsley Capital Partners, in conjunction with other investors. Through their close partnership with the University of Oxford, they have access to world leading scientists, expertise, and facilities.
OCT is already gathering momentum and while research activity is in its early stages, a CEO is required to lead the business through its growth and stages of evolution, creating value for OCT’s investors and introducing cannabinoid-based medications to market.
Specific responsibilities will include:
Required experience includes:
It is OCT’s vision to become a global leader in cannabinoid-based therapies, improving the quality of life for millions of patients. If you have the experience and ambition to lead OCT to achieve this vision please send apply through the advert.
Or select a sector to speak to one of our specialists